New Drug Patents by Country 2026
Pharma Patent Share 2020-2022
1%
2%
3%
4%
5%
6%
7%
8%
9%
10%
Country | Pharma Patent Share 2020-2022↓ | Medicines Patent Filings 2013 | MLEM Drugs Patented 2013 | Triadic Pharma Patents 1999-2012 | EPO Pharma Patents 1999-2012 | USPTO Pharma Patents 1999-2012 | |
|---|---|---|---|---|---|---|---|
 | Switzerland | 9.8% | 171 | 257 | 285 | ||
 | United Kingdom | 7.9% | 410 | 578 | 749 | ||
 | United States | 6.9% | 2,581 | 3,926 | 9,435 | ||
 | India | 4.7% | 60 | 11 | |||
 | France | 4.4% | 340 | 501 | 569 | ||
 | Netherlands | 4.2% | 80 | 170 | 181 | ||
 | Germany | 2.4% | 606 | 970 | 1,029 | ||
 | South Korea | 2.2% | 115 | 127 | 243 | ||
 | China | 1.8% | 134 | 16 | |||
 | Japan | 1.4% | 621 | 835 | 1,123 | ||
 | Indonesia | 38 | 12 | ||||
 | Brazil | 62 | 13 | ||||
 | Mexico | 111 | 18 | 4 | 11 | 15 | |
 | Philippines | 71 | 13 | ||||
 | Turkey | 61 | 12 | 2 | 23 | 7 | |
 | Thailand | 24 | 8 | ||||
 | South Africa | 50 | 15 | ||||
 | Italy | 152 | 278 | 299 | |||
 | Colombia | 24 | 8 | ||||
 | Spain | 74 | 150 | 134 | |||
 | Canada | 137 | 253 | 492 | |||
 | Ukraine | 28 | 11 | ||||
 | Poland | 5 | 13 | 11 | |||
 | Malaysia | 32 | 10 | ||||
 | Australia | 77 | 127 | 192 | |||
 | Chile | 2 | 5 | 7 | |||
 | Romania | 79 | 16 | ||||
 | Belgium | 71 | 125 | 152 | |||
 | Sweden | 104 | 147 | 202 | |||
 | Czechia | 5 | 13 | 12 | |||
 | Azerbaijan | 23 | 7 | ||||
 | Portugal | 6 | 10 | 10 | |||
 | Greece | 2 | 10 | 10 | |||
 | Israel | 79 | 160 | 290 | |||
 | Hungary | 17 | 27 | 30 | |||
 | Austria | 44 | 78 | 83 | |||
 | Belarus | 24 | 7 | ||||
 | Kyrgyzstan | 23 | 7 | ||||
 | Bulgaria | 67 | 14 | ||||
 | Serbia | 37 | 9 | ||||
 | Denmark | 91 | 150 | 198 | |||
 | Norway | 22 | 35 | 44 | |||
 | Finland | 22 | 33 | 44 | |||
 | Slovakia | 1 | 2 | 3 | |||
 | Ireland | 13 | 24 | 36 | |||
 | New Zealand | 14 | 24 | 38 | |||
 | Albania | 37 | 10 | ||||
 | Slovenia | 5 | 27 | 13 | |||
 | Latvia | 3 | 5 | 4 | |||
 | North Macedonia | 37 | 10 | ||||
 | Estonia | 1 | 2 | 2 | |||
 | Luxembourg | 1 | 2 | 2 | |||
 | Iceland | 2 | 4 | 6 |
- Triadic, EPO, and USPTO data refer to different patent systems used to measure pharmaceutical innovation. Triadic patents are those filed in the U.S., Europe, and Japan, reflecting globally significant inventions. EPO patents are filed with the European Patent Office, while USPTO patents are filed with the U.S. Patent and Trademark Office.
- The top 10 origins were selected based on their 2020–2022 total published applications.
- MLEM (Model List of Essential Medicines) is a list published by the World Health Organization (WHO) identifying medicines considered essential for meeting the most important health care needs of a population.
- The dataset includes pharmaceutical patent data from different time periods and perspectives, capturing both recent patent distribution, patents for essential medicines, and filings across major international patent systems. This allows comparison of trends by scope, focus, geography, and period.
